GILEAD SCIENCES, INC. is 18.4x more valuable than BIO-TECHNE Corp by market capitalization ($151.05 B vs $8.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TECH | GILD |
|---|---|---|
| Market cap | $8.22 B | $151.05 B |
| US-listed rank | #1055 | #99 |
| Revenue (latest FY) | $1.22B | $29.44B |
| Net income (latest FY) | $73.40M | $8.51B |
| Net margin | 6.0% | 28.9% |
| P/E (trailing FY) | 112.0 | 17.7 |
| SEC filings | 1,229 | 981 |
GILEAD SCIENCES, INC. is 18.4x more valuable than BIO-TECHNE Corp by market capitalization ($151.05 B vs $8.22 B).
In their latest fiscal years, BIO-TECHNE Corp reported $1.22B in revenue while GILEAD SCIENCES, INC. reported $29.44B.
Full pages: BIO-TECHNE Corp and GILEAD SCIENCES, INC., or browse the full rankings.